The antiviral drug Paxlovid appears to reduce the risk of dying from COVID-19 by 79% and decrease hospitalizations by 73% in at-risk patients who are ages 65 and older, according to a new study published in The New England Journal of Medicine.
Anthony Fauci, MD, the chief medical adviser to President Joe Biden, said Tuesday that he went through a “Paxlovid rebound” that can occur after taking the antiviral to recover from COVID-19.
Covid-19 Antiviral Pill: Britain became the first country in the world to approve COVID-19 antiviral pill that was jointly developed by U.S based Merck and Ridgeback Biotherapeutics.